blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3972612

EP3972612 - ORAL CARE COMPOSITIONS AND METHODS OF USE [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  02.02.2024
Database last updated on 03.09.2024
FormerExamination is in progress
Status updated on  06.10.2023
FormerRequest for examination was made
Status updated on  25.02.2022
FormerThe international publication has been made
Status updated on  15.01.2021
Formerunknown
Status updated on  24.04.2020
Most recent event   Tooltip02.02.2024Withdrawal of applicationpublished on 06.03.2024  [2024/10]
Applicant(s)For all designated states
Colgate-Palmolive Company
300 Park Avenue
New York, NY 10022 / US
[2022/13]
Inventor(s)01 / DAEP, Carlo
226 Coleridge Street
Brooklyn, New York 11235 / US
02 / THOMSON, Paul
281 Shady Oak Court
Piscatatway, New Jersey 08854 / US
03 / RAJAH, Divino
305 Pitney Place
Morristown, New Jersey 07960 / US
 [2022/13]
Representative(s)Wibbelmann, Jobst
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstrasse 2
81541 München / DE
[N/P]
Former [2022/13]Wibbelmann, Jobst
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstrasse 2
81541 München / DE
Application number, filing date20718883.013.03.2020
[2022/13]
WO2020US22532
Priority number, dateUS201962868623P28.06.2019         Original published format: US 201962868623 P
[2022/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020263364
Date:30.12.2020
Language:EN
[2020/53]
Type: A1 Application with search report 
No.:EP3972612
Date:30.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2020 takes the place of the publication of the European patent application.
[2022/13]
Search report(s)International search report - published on:EP30.12.2020
ClassificationIPC:A61K33/30, A61K33/24, A61P43/00, A61Q11/00, A61K8/19
[2022/13]
CPC:
A61P43/00 (EP); A61K33/30 (EP,US); A61K31/198 (US);
A61K33/16 (US); A61K33/24 (EP); A61K47/02 (US);
A61K47/10 (US); A61K47/38 (US); A61K8/19 (EP);
A61K8/27 (EP); A61K9/0053 (US); A61K9/06 (US);
A61Q11/00 (EP,US) (-)
C-Set:
A61K33/24, A61K2300/00 (EP);
A61K33/30, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/13]
TitleGerman:MUNDPFLEGEZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG[2022/13]
English:ORAL CARE COMPOSITIONS AND METHODS OF USE[2022/13]
French:COMPOSITIONS DE SOINS BUCCO-DENTAIRES ET PROCÉDÉS D'UTILISATION[2022/13]
Entry into regional phase22.12.2021National basic fee paid 
22.12.2021Designation fee(s) paid 
22.12.2021Examination fee paid 
Examination procedure22.12.2021Examination requested  [2022/13]
22.12.2021Date on which the examining division has become responsible
21.07.2022Amendment by applicant (claims and/or description)
05.10.2023Despatch of a communication from the examining division (Time limit: M04)
26.01.2024Application withdrawn by applicant  [2024/10]
Fees paidRenewal fee
28.03.2022Renewal fee patent year 03
27.03.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]US2003206874  (DOYLE MATTHEW JOSEPH [US], et al) [X] 1,4-8,12-15,21 * claims 1-12 * * paragraphs [0044] , [0045] * * Formulation 3E/Example 3 * [Y] 1-22[I] 1-22;
 [XYI]US2017367948  (THOMSON PAUL [US], et al) [X] 1,4,12-21 * paragraphs [0103] - [0108]; examples 1-9 * * claims 1-22 * [Y] 1-22 [I] 22;
 [XY]US2018168957  (REGE AARTI [US], et al) [X] 1,4,12-15,21,22 * paragraph [0010]; examples 1-4; claims 1-15 * [Y] 1-22;
 [XY]US2018168978  (REGE AARTI [US], et al) [X] 1-4,12-22 * paragraphs [0020] - [0091]; examples 1-2; claims 1-24 * [Y] 1-22
by applicantUS3535421
 US3678154
 US4842847
 US4866161
 US4885155
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.